{"id":8353,"date":"2020-07-09T21:55:34","date_gmt":"2020-07-10T02:55:34","guid":{"rendered":"https:\/\/shockwavemedical.com\/education\/carlo-di-mario-imaging-with-ivl\/"},"modified":"2024-12-11T08:29:58","modified_gmt":"2024-12-11T14:29:58","slug":"carlo-di-mario-imaging-with-ivl","status":"publish","type":"post","link":"https:\/\/shockwavemedical.com\/de\/education\/carlo-di-mario-imaging-with-ivl\/","title":{"rendered":"Q&A: Imaging with IVL in Concentric & Eccentric Ca2+"},"content":{"rendered":"\n
\n\t
\n\t\t

Prof. Carlo Di Mario, Director of Structural Interventional Cardiology at the Careggi University Hospital in Florence, Italy, and other cardiologists in Florence recently published their initial real-world experience when using intravascular imaging while treating coronary lesions with\u00a0intravascular lithotripsy (IVL).<\/p>\n

The publication in\u00a0Cardiovascular Revascularization Medicine<\/em>, entitled \u201cIntravascular imaging to guide lithotripsy in concentric and eccentric calcific coronary lesions<\/a>,\u201d showed similar positive outcomes in more complex real-world patients who failed other calcium modification strategies before turning to imaging-guided IVL, compared to the patients treated with de novo lesions in DISRUPT CAD I & II. What\u2019s more, his analysis also looked at the arc of calcium to see if there were any differences in outcomes. His results, in his own words, were \u201cunexpected.\u201d<\/p>\n

We had the privilege of connecting with Prof. Di Mario to learn more about the publication, its key takeaways and some of his practical recommendations as one of the earliest users of\u00a0Shockwave IVL\u00a0in the coronaries.<\/p>\n

Read the publication<\/a>\u00a0and enjoy his Q&A:<\/p>\n

\u00a0<\/p>\n

Question:\u00a0 What are the current challenges in treating calcified eccentric lesions and solely using angiography to guide IVL delivery?<\/strong><\/p>\n

Prof. Di Mario:\u00a0<\/strong>\u00a0The main issue is that we have no certainty, only based on angiography, of the true extension of the calcium arc. Thinner superficial calcium sheets can be less visible than the contralateral thicker layers giving the false impression of an eccentric calcification and vice versa parallel rails of calcium can be present in one view even below the 180 degree arc. This is the main limitation of the manuscript that Nef and colleagues recently submitted to Circulation Interventions on behalf of all the DISRUPT I and II Investigators. The distinction was only based on the careful angiographic review done at Yale by the Angiographic Core Lab of Dr Alexandra Lansky which overcomes the subjectivity of the Investigators but cannot eliminate the inherent limitations of angiography, known since the seminal IVUS paper of Mintz et al in the late nineties.<\/p>\n

\u00a0<\/p>\n

\"medical<\/p>\n

Question:\u00a0 What were your study\u2019s goals \u2013 what did you seek to understand going into the research?<\/strong><\/p>\n

Prof. Di Mario:\u00a0<\/strong>\u00a0Our study is much smaller than Nef\u2019s combined analysis of 180 patients with only 31 lesions in 28 patients but they came not from the strict adherence to the DISRUPT trial protocol but from the real world, with patients selected based on severe calcium load confirmed with IVUS\/OCT, patients that failed predilatation, patients with Rotablator used to cross the lesion initially but still with an incomplete final lesion expansion. More importantly, in all these patients the distinction between eccentric and concentric lesions was based on the gold standard, IVUS or OCT.<\/p>\n

\u00a0<\/p>\n

Question:\u00a0 What were your study\u2019s key findings?<\/strong><\/p>\n

Prof. Di Mario:\u00a0<\/strong>\u00a0Lesion minimal lumen area measured with OCT\/IVUS was 7.06 mm2<\/sup> in the eccentric lesion group and 7.13 mm2<\/sup> in the concentric lesion group.<\/p>\n

\u00a0<\/p>\n

Question:\u00a0 Why was the similar stent expansion and acute gain observed in both concentric and eccentric calcified lesions an unexpected outcome?<\/strong><\/p>\n

Prof. Di Mario:\u00a0<\/strong>\u00a0We expected that concentric lesions had greater potential benefit from IVL and some expert users were even supporting the idea that, in order to select these lesions appropriately, IVUS\/OCT was indispensable before IVL. On the contrary, we had similar findings to the angiographic analysis from DISRUPT I and II where residual stenosis >30% was less than 3% with QCA both in eccentric and concentric lesions. This suggests that the pragmatic approach proposed in these trials with angiography only to select patients for IVL obtains excellent outcome without complications in both types of lesions.<\/p>\n

\u00a0<\/p>\n

Question:\u00a0 How does the use of imaging change the way that someone uses IVL?<\/strong><\/p>\n

Prof. Di Mario:\u00a0<\/strong>\u00a0I think the main difference is the ability to avoid risky high pressure dilatations with balloon dogboning and possible vessel rupture in lesions meeting the classical Fujino OCT criteria or anyway with >180 degrees and long calcifications with IVUS.<\/p>\n

\u00a0<\/p>\n

Question:\u00a0 From your experience, are there certain lesions characteristics or anatomical locations that most often benefit from imaging-guided IVL?<\/strong><\/p>\n

Prof. Di Mario:\u00a0<\/strong>\u00a0Long lesions, especially in tapering vessels such as the proximal-mid LAD, may require more than one IVL balloon, both because multiple activations are needed along the vessels and because the more proximal balloon diameter should be \u00bd-1 mm greater than the diameter of the distal balloon. IVUS\/OCT are ideal for these complex lesions and very helpful, especially OCT, to confirm effective calcium cracking and optimal final stent expansion and strut apposition.<\/p>\n

\u00a0<\/p>\n

Question:\u00a0 How would you counsel someone without access to imaging to optimize their use of IVL?<\/strong><\/p>\n

Prof. Di Mario:\u00a0\u00a0<\/strong>Even in expert imaging centers there would be instances when this is difficult to use, like in primary PCI in the middle of the night or due to cost or organizational difficulties. Long rails of calcium in proximal large vessels were the chief inclusion criterion in the DISRUPT trials. Wait a second before injecting contrast to examine the running images of the vessel without contrast in various views. As the angiographic DISRUPT sub-analysis showed and our imaging study confirmed all the lesions qualifying angiographically have a benefit from IVL both in terms of optimal expansion and reduction of complications.<\/p>\n

\n

Professor Carlo Di Mario is a paid consultant of Shockwave Medical.<\/span><\/p>\n

Coronary Important Safety Information:<\/span><\/strong><\/p>\n

In the United States: Rx only.<\/span><\/p>\n

Indications for Use\u2014The Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2\u00a0Coronary IVL Catheter is indicated for lithotripsy-enabled, low-pressure balloon dilatation of severely calcified, stenotic\u00a0de novo\u00a0coronary arteries prior to stenting. <\/span><\/p>\n

Contraindications\u2014The Shockwave C2\u00a0Coronary IVL System is contraindicated for the following: This device is not intended for stent delivery. This device is not intended for use in carotid or cerebrovascular arteries. <\/span><\/p>\n

Warnings\u2014 Use the IVL Generator in accordance with recommended settings as stated in the Operator\u2019s Manual. The risk of a dissection or perforation is increased in severely calcified lesions undergoing percutaneous treatment, including IVL. Appropriate provisional interventions should be readily available. Balloon loss of pressure was associated with a numerical increase in dissection which was not statistically significant and was not associated with MACE.\u00a0 Analysis indicates calcium length is a predictor of dissection and balloon loss of pressure.\u00a0 IVL generates mechanical pulses which may cause atrial or ventricular capture in bradycardic patients. In patients with implantable pacemakers and defibrillators, the asynchronous capture may interact with the sensing capabilities. Monitoring of the electrocardiographic rhythm and continuous arterial pressure during IVL treatment is required.\u00a0 In the event of clinically significant hemodynamic effects, temporarily cease delivery of IVL therapy. <\/span><\/p>\n

Precautions\u2014 Only to be used by physicians trained in angiography and intravascular coronary procedures. Use only the recommended balloon inflation medium. Hydrophilic coating to be wet only with normal saline or water and care must be taken with sharp objects to avoid damage to the hydrophilic coating.\u00a0Appropriate anticoagulant therapy should be administered by the physician.\u00a0Precaution should be taken when treating patients with previous stenting within 5mm of target lesion. <\/span><\/p>\n

Potential adverse effects consistent with standard based cardiac interventions include\u2013 Abrupt vessel closure \u2013 Allergic reaction to contrast medium, anticoagulant and\/or antithrombotic therapy-Aneurysm-Arrhythmia-Arteriovenous fistula-Bleeding complications-Cardiac tamponade or pericardial effusion-Cardiopulmonary arrest-Cerebrovascular accident (CVA)-Coronary artery\/vessel occlusion, perforation, rupture or dissection-Coronary artery spasm-Death-Emboli (air, tissue, thrombus or atherosclerotic emboli)-Emergency or non-emergency coronary artery bypass surgery-Emergency or non-emergency percutaneous coronary intervention-Entry site complications-Fracture of the guide wire or failure\/malfunction of any component of the device that may or may not lead to device embolism, dissection, serious injury or surgical intervention-Hematoma at the vascular access site(s)-Hemorrhage-Hypertension\/Hypotension-Infection\/sepsis\/fever-Myocardial Infarction-Myocardial Ischemia or unstable angina-Pain-Peripheral Ischemia-Pseudoaneurysm-Renal failure\/insufficiency-Restenosis of the treated coronary artery leading to revascularization-Shock\/pulmonary edema-Slow flow, no reflow, or abrupt closure of coronary artery-Stroke-Thrombus-Vessel closure, abrupt-Vessel injury requiring surgical repair-Vessel dissection, perforation, rupture, or spasm. Risks identified as related to the device and its use:\u00a0Allergic\/immunologic reaction to the catheter material(s) or coating-Device malfunction, failure, or balloon loss of pressure leading to device embolism, dissection, serious injury or surgical intervention-Atrial or ventricular extrasystole-Atrial or ventricular capture. <\/span><\/p>\n

Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events.\u00a0\u00a0https:\/\/shockwavemedical.com\/IFU <\/a><\/span><\/p>\n

Please contact your local Shockwave representative for specific country availability and refer to the Shockwave C2\u00a0instructions for use containing important safety information.<\/span><\/p>\n\t<\/div>\n\t<\/section>","protected":false},"excerpt":{"rendered":"

Prof. Carlo Di Mario recently published initial real-world experience when using intravascular imaging while treated coronary lesions lesions with Shockwave IVL.<\/p>\n","protected":false},"author":2,"featured_media":3751,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":[207],"meta":{"_acf_changed":true,"content-type":"","footnotes":""},"categories":[3],"tags":[],"disease-state":[161],"education-topic":[185,197],"product-tag":[257,253],"specialty":[297,330,334,338,346],"technology":[318],"class_list":["post-8353","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-unkategorisiert","disease-state-coronary-artery-disease-de","education-topic-best-practices-de","education-topic-peer-to-peer-de","format-article-de","product-tag-shockwave-c2-de-2","product-tag-shockwave-c2-de","specialty-fellows-residents-de","specialty-interventional-cardiologists-de","specialty-interventional-radiologists-de","specialty-nurses-technologists-de","specialty-vascular-surgeons-de","technology-coronary-ivl-de"],"acf":[],"_links":{"self":[{"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/posts\/8353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/comments?post=8353"}],"version-history":[{"count":0,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/posts\/8353\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/media\/3751"}],"wp:attachment":[{"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/media?parent=8353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/categories?post=8353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/tags?post=8353"},{"taxonomy":"disease-state","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/disease-state?post=8353"},{"taxonomy":"education-topic","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/education-topic?post=8353"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/format?post=8353"},{"taxonomy":"product-tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/product-tag?post=8353"},{"taxonomy":"specialty","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/specialty?post=8353"},{"taxonomy":"technology","embeddable":true,"href":"https:\/\/shockwavemedical.com\/de\/wp-json\/wp\/v2\/technology?post=8353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}